Hopes and Cures

 
Alzheimer’s Drug Discovery Foundation
A new way to look at funding
The Alzheimer’s Drug Discovery Foundation (ADDF) raises money and awards grants to academic and biotechnology industry scientists who are conducting drug discovery research for Alzheimer’s Disease, related dementias and cognitive aging.
The way research is funded is evolving and by employing a venture capital model, [...]

Filed under: Finding Cures, SBIR, patient groups, venture capital | Tagged: Allon, Alzheimer's disease, Comentis, Estee Lauder, Fillit, SBIR | No Comments »

We chatted with Virginia Ladd, President and Executive Director of the American Autoimmune Related Disease Association.
What is the scope of your work?
There are over 100 types of autoimmune related diseases, including lupus, type I diabetes, scleroderma, celiac, multiple sclerosis, Crohn’s disease, autoimmune hepatitis, rheumatoid arthritis, Graves’ disease, and Sjogren’s syndrome. The NIH estimates that 23.5 [...]

Filed under: Finding Cures, Non Profit, SBIR, patient groups | Tagged: Autoimmune Related Disease, celiac, crohn's disease, multiple sclerosis, Virginia Ladd | 1 Comment »

California Biotech Law Blog posted a summary of recent House hearings on reauthorizing the Small Business Innovation Research Program (SBIR).

In the world of biotechnology, the principle at stake is the United States’s claim to be an innovation engine in the global economy. Our members and their scientists are developing disease treatments and cures at a rapid rate, but because these cutting-edge treatments are so new, it takes 10-15 years before they reach the market. In the meantime, they thrive on traditional venture capital and the government’s version of VC: the SBIR program.

If Congress wants to perpetuate the image – and reality – of the US as the center of innovation, they must adapt the criteria for SBIR grants to match the reality for these budding treatments and burgeoning companies.

Filed under: BIO, Congress, Finding Cures, SBIR, venture capital | Tagged: biotech, MS, Parkinson's, SBIR | No Comments »

What is State Science & Technology Institute (SSTI)?
It is a national nonprofit organization based outside of Columbus, OH, that is dedicated to leading, supporting, and strengthening public-private efforts to improve regional economies through science, technology and innovation.   Part of SSTI’s mission is to serve as a neutral convener for discussion and advancement of key issues [...]

Filed under: Congress, Finding Cures, Non Profit | Tagged: House Small Business Committee, Innovation, Mark Skinner, Non Profit, research, SBIR, SSTI | No Comments »

 
The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. We spoke with Mary Dwight about her organization and the important work they do.
 Can you tell us a bit about CFF’s purpose?  The Cystic Fibrosis Foundation is the leader in developing drugs to treat and [...]

Filed under: Congress, Finding Cures, SBIR, patient groups | Tagged: Congress, cystic fibrosis, patient groups, SBIR | 2 Comments »

from www.youtube.com posted with vodpod

Filed under: Finding Cures, SBIR | No Comments »

Getting financing can be difficult. This news article from the Worcester Telegram & Gazette demonstrates the importance of SBIR funding.
“Not all start-up companies have been able to tap into venture capital to fund their businesses. Mr. Prescott of Crescent Innovations has secured federal Small Business Innovation Research funding, grants and money from [...]

Filed under: Finding Cures, SBIR, venture capital | Tagged: angel investors, biotechnology, financing, SBIR, start-up, venture capital | No Comments »

Putting the “I” back — that is the “I” in innovation. While we consider SBIR program to be critical to the commercialization of biotechnology for our industry, it is clear that others do not share this view ordiffer on the ways in which this problem should be fixed. For example, Kristie Prinz wrote [...]

Filed under: Finding Cures | Tagged: biotechnology, Congress, Innovation, National Research Council, NIH, SBIR | No Comments »

My name is Cartier Esham.  I am the new Director of Health and Regulatory Affairs for BIO’s Emerging Companies.  The purpose of this blog is to generate discussion surrounding important issues facing the biotechnology industry and patient focused organizations.  Before coming to Washington, D.C., I received my doctorate in microbial ecology and have a great [...]

Filed under: Finding Cures | Tagged: biotechnology, cures, healthcare, SBIR, small business administration | 1 Comment »